I agree that this site is using cookies. You can find further informations here.
X
Yu, Guopan
62  results:
Search for persons X
?
1

Decreasing circ_0014614 promotes the differentiation of bon..:

Yu, Guopan ; Chen, Xiaofan ; Lu, Weixiang...
Blood Cells, Molecules, and Diseases.  107 (2024)  - p. 102855 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Homoharringtonine may help improve the outcomes of venetocl..:

Yin, Zhao ; Yao, Zurong ; Chen, Dandan...
Journal of Cancer Research and Clinical Oncology.  150 (2024)  7 - p. , 2024
Link: https://doi.org/10.1007/..
 
?
3

Trafficking circuit of CD8+ T cells between the intestine a..:

Shi, Rong-Yi ; Zhou, Neng ; Xuan, Li...
Nature Cell Biology.  , 2024
Link: https://doi.org/10.1038/..
 
?
4

Clinical and genetic characteristics predict outcomes of ac..:

Weng, Guangyang ; Huang, Jingya ; An, Na...
Cancer Medicine.  13 (2024)  2 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
5

Impact of measurable residual disease in combination with C..:

Jia, Xi ; Liao, Naying ; Yu, Sijian...
Cancer Medicine.  13 (2024)  4 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
6

Impact of different CEBPA mutations on therapeutic outcome ..:

Zhao, Yu ; Huang, Yun ; Jiang, Ling...
Annals of Hematology.  , 2024
Link: https://doi.org/10.1007/..
 
?
7

Identifying prognostic biomarker related to immune infiltra..:

Lu, Weixiang ; Yu, Guopan ; Li, Yanlin...
Clinical and Experimental Medicine.  23 (2023)  8 - p. 4553-4562 , 2023
Link: https://doi.org/10.1007/..
 
?
8

Sorafenib plus triplet therapy with venetoclax, azacitidine..:

Yu, Sijian ; Zhang, Yu ; Yu, Guopan...
Journal of Internal Medicine.  295 (2023)  2 - p. 216-228 , 2023
Link: https://doi.org/10.1111/..
 
?
9

Changing epidemiology, microbiology and mortality of bloods..:

Cai, Linjing ; Chen, Huan ; Wei, Yongqiang...
BMJ Open.  13 (2023)  12 - p. e078510 , 2023
Link: https://doi.org/10.1136/..
 
?
10

Venetoclax Combined with Azacitidine and Homoharringtonine ..:

Jin, Hua ; Zhang, Yu ; Yu, Sijian...
Journal of Hematology & Oncology.  16 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
11

Hypomethylating agents plus modified priming regimens compa..:

Weng, Guangyang ; Huang, Jingya ; He, Xin...
Annals of Hematology.  102 (2023)  12 - p. 3369-3381 , 2023
Link: https://doi.org/10.1007/..
 
?
12

Risk-directed therapy based on genetics and MRD improves th..:

Xu, Dan ; Yang, Ying ; Yin, Zhao...
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
13

Cidofovir, a choice for salvage treatment of cytomegaloviru..:

Yin, Zhao ; Sun, Jing ; Yang, Ying...
Transplant Infectious Disease.  24 (2022)  2 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
14

A phase 2 study of sorafenib combined with conventional the..:

Chen, Xiaoxia ; Huang, Junwei ; Xu, Na...
Cancer.  128 (2022)  11 - p. 2138-2147 , 2022
Link: https://doi.org/10.1002/..
 
?
15

Concomitant targeting of FLT3 and BTK overcomes FLT3 inhibi..:

Zhang, Weiguo ; Yu, Guopan ; Zhang, Hongying...
Haematologica.  108 (2022)  6 - p. 1500-1514 , 2022
Link: https://doi.org/10.3324/..
 
1-15